PMID: 11920608Mar 29, 2002Paper

Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status

International Journal of Cancer. Journal International Du Cancer
Sabine VioletteThécla Lesuffleur

Abstract

Defects in apoptosis have been implicated in chemoresistance of colon cancer cells. We report here the ability to resist to 5-fluorouracil-induced apoptosis of 8 colon cancer cell lines differing in p53 and bax status: p53(-/0)bax(+/+) for TC7, SW480, HT-29; p53(+/+)bax(-/-) for LS174T, LoVo; p53(+/+) bax(+/-) for HCT116; p53(+/+) or p53(+/0)bax(+/+) for LS513 or HCT-EB, respectively. To approximate to the in vivo therapy, the cell lines were exposed to a long-term treatment of 5-FU. The analysis of proteins implicated in the apoptotic pathway has shown that the independent analysis of p53 or bax status was not sufficient to predict the extent of drug-resistance of all cell lines. In p53(+/+) cell lines but not in p53(-/0) cell lines, a low level of the pro-apoptotic Bax protein was correlated with a greater resistance of cells to 5-FU. In addition, we found that high levels of anti-apoptotic Bcl-2 and Bcl-x(L) proteins combined with a low level of Bax were correlated to high 5-FU resistance of wild-type p53 cell lines. The same correlation was obtained for 2 out of 3 mutated p53 cell lines. In conclusion, the relative levels of Bcl-2, Bcl-x(L) and Bax may altogether contribute to determine the resistance of a majority of colon...Continue Reading

References

Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·J L CazinA Demaille
Nov 11, 1991·International Journal of Cancer. Journal International Du Cancer·T LesuffleurA Zweibaum
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Feb 24, 1995·Cell·E M MiyashitaD A Thorley-Lawson
Nov 4, 1994·Science·S W LoweT Jacks
Jan 1, 1997·British Journal of Cancer·N el-MahdaniB Hermelin
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I SturmP T Daniel
Aug 3, 1999·The Journal of Clinical Investigation·F BunzB Vogelstein
Aug 13, 1999·Genes & Development·A GrossS J Korsmeyer
Apr 29, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G J PetersH M Pinedo
Aug 31, 2000·Japanese Journal of Cancer Research : Gann·M E NitaH Nagawa
Oct 25, 2000·British Journal of Cancer·J F MirjoletJ L Merlin
Nov 4, 2000·Science·L ZhangB Vogelstein
Mar 30, 2001·The Journal of Biological Chemistry·V MikhailovP Saikumar

❮ Previous
Next ❯

Citations

Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Sabine VioletteThécla Lesuffleur
Sep 15, 2004·Cancer Chemotherapy and Pharmacology·Gabriella CalvielloPaola Palozza
Jan 7, 2009·Cancer Chemotherapy and Pharmacology·Cao YangZhenfeng Duan
Apr 12, 2011·Cancer Chemotherapy and Pharmacology·Cristina P R XavierCristina Pereira-Wilson
Mar 29, 2007·International Journal of Colorectal Disease·Ivana GrivicichAdriana Brondani da Rocha
Oct 27, 2004·Journal of Cancer Research and Clinical Oncology·S KapitzaB Marian
Dec 1, 2006·Apoptosis : an International Journal on Programmed Cell Death·Jens Martin WernerHans Jürgen Steinfelder
Dec 5, 2008·Apoptosis : an International Journal on Programmed Cell Death·Cao YangZhenfeng Duan
Jan 10, 2012·Apoptosis : an International Journal on Programmed Cell Death·Kristel KemperJan Paul Medema
Jul 1, 2005·Digestive Diseases and Sciences·Hassan AshktorabDuane T Smoot
Oct 15, 2013·Pathology Oncology Research : POR·Mehdi ManoochehriBahram Kazemi
Jan 19, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Haitao QingBo Jiang
Aug 10, 2012·The British Journal of Nutrition·Virginie GranciClaude Pichard
Sep 1, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kazuya NakamuraHiroshi Kiwada
Apr 19, 2007·Clinical and Experimental Pharmacology & Physiology·Xiao-Yong LeiDuan-Fang Liao
Dec 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenji OkumuraFrank A Sinicrope
Nov 16, 2013·International Journal of Nanomedicine·Mingrong ChengZhiping Zhang
Jul 25, 2012·World Journal of Gastroenterology : WJG·Masakatsu Numata, Takashi Oshima
Feb 20, 2014·International Journal of Molecular Sciences·Hyun Sook LeeJung Han Yoon Park
Jun 7, 2005·Expert Review of Molecular Diagnostics·Farid E Ahmed
Jul 6, 2014·International Journal of Molecular Sciences·Fung Lin YongChee Wei Law
Apr 11, 2006·Journal of Drug Targeting·Lan-Fang FengDuan-Fang Liao
Sep 3, 2013·The Journal of Surgical Research·Secil AkAbdullah Zorluoglu
Dec 5, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Shanmugam Hemaiswarya, Mukesh Doble
Jul 31, 2012·The Journal of Nutritional Biochemistry·Cristina P R XavierCristina Pereira-Wilson
Jan 27, 2009·Biochimica Et Biophysica Acta·Suzanne Hector, Jochen H M Prehn
Oct 24, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Shigang LinDe-Xing Hou
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Wolfgang M SchmidtRobert M Mader
Sep 29, 2004·Journal of Cellular Physiology·Uwe WenzelHannelore Daniel
Sep 28, 2005·International Journal of Cancer. Journal International Du Cancer·Chihiro KondoFumitaka Kikkawa
Apr 20, 2007·Journal of Surgical Oncology·S G PrabhudesaiP Ziprin
Oct 20, 2011·The Journal of Pathology·Anke H Sillars-HardebolGerrit A Meijer
Mar 22, 2016·European Journal of Pharmacology·Karen BolandJochen H M Prehn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.